{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:37:41Z","timestamp":1793353061178,"version":"4.5.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Although the cachexia index (CXI) is a well-established prognostic predictor in gastric cancer (GC) patients, its effectiveness in patients with locally advanced gastric cancer (LAGC) who have undergone neoadjuvant chemotherapy (NACT) remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This multicenter study included 600 LAGC patients treated with NACT from January 2010 to June 2022. A modified CXI was constructed based on Random Forest model, calculated as\n                      <jats:italic toggle=\"yes\">(post-NACT subcutaneous adipose tissue area at L3)\u00a0\u00d7 (post-NACT serum albumin)\/(post-NACT platelet count)<\/jats:italic>\n                      . Patients were categorized into mCXI-low and mCXI-high.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In the training cohort, mCXI outperformed the traditional CXI in predicting of overall survival (OS) and tumor regression grades. The mCXI-high group had a significantly higher 3-year OS (73.0% vs. 58.9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.002), recurrence-free survival (67.7% vs. 50.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.002), and disease-specific survival (74.4% vs. 62.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.012). Multivariate analysis confirmed that mCXI as an independent prognostic factor. The recurrence rate was significantly lower in the mCXI-high group (33.0% vs. 52.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The mCXI-high group also had a lower recurrence rate (33.0% vs. 52.6%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and a delayed recurrence peak (33.51 vs. 7.11\u00a0months). Similar results were obtained in the validation cohort. Further analysis showed that in mCXI-low patients with ypStage III disease, receiving more than 4 cycles of adjuvant chemotherapy (AC) significantly improved survival (3-year OS: 43.7% vs. 25.0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.007). In mCXI-high patients, 4\u20136 AC cycles yielded optimal outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>mCXI was associated with the overall prognosis in patients with LAGC underwent NACT, is superior to traditional CXI, and may serve as a decision-making tool for guiding personalized postoperative AC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000002707","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:00:14Z","timestamp":1749718814000},"page":"5868-5881","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Development and validation of a novel modified cancer cachexia index in patients with locally advanced gastric cancer undergoing neoadjuvant chemotherapy: a multicenter cohort study"],"prefix":"10.1097","volume":"111","author":[{"given":"Ling-Kang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Long","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Bin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Digestive Endoscopy, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hui","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Tan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ming","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4971-2896","authenticated-orcid":false,"given":"Jian-Wei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"R1-20261030","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20261030","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin. 2020 Jul;70(4):313]","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","article-title":"Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1470-2045(21)00297-7","article-title":"Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial [published correction appears in Lancet Oncol. 2021;22(8):e347]","volume":"22","author":"Zhang","year":"2021","journal-title":"Lancet Oncol"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.20.02914","article-title":"PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer","volume":"39","author":"Kang","year":"2021","journal-title":"J Clin Oncol"},{"key":"R7-20261030","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4137\/CMO.S30891","article-title":"Cachexia index in advanced non-small-cell lung cancer patients","volume":"9","author":"Jafri","year":"2015","journal-title":"Clin Med Insights Oncol"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"znae098","DOI":"10.1093\/bjs\/znae098","article-title":"Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study","volume":"111","author":"Brown","year":"2024","journal-title":"Br J Surg"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.3390\/cancers14184400","article-title":"Cachexia index as a prognostic indicator in patients with gastric cancer: a retrospective study","volume":"14","author":"Gong","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jcsm.13205","article-title":"The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia","volume":"14","author":"Xie","year":"2023","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1159\/000534244","article-title":"The cancer cachexia index can be used to prognostically predict patients with gastric cancer undergoing gastrectomy","volume":"79","author":"Sakurai","year":"2023","journal-title":"Ann Nutr Metab"},{"key":"R13-20261030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jcsm.12391","article-title":"Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study","volume":"10","author":"da Rocha","year":"2019","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R14-20261030","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1097\/JS9.0000000000001268","article-title":"The STROCSS 2024 guideline: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"110","author":"Rashid","year":"2024","journal-title":"Int J Surg"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"108367","DOI":"10.1016\/j.ejso.2024.108367","article-title":"Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy","volume":"50","author":"Zhang","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"228e47","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"997e1006","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metabol"},{"key":"R19-20261030","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1016\/j.clnu.2021.06.021","article-title":"Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: a multicenter, international study","volume":"40","author":"Lin","year":"2021","journal-title":"Clin Nutr"},{"key":"R20-20261030","doi-asserted-by":"crossref","first-page":"e0204529","DOI":"10.1371\/journal.pone.0204529","article-title":"Tutorial for using SliceOmatic to calculate thigh area and composition from computed tomography images from older adults","volume":"13","author":"Dennis","year":"2018","journal-title":"PLoS ONE"},{"key":"R21-20261030","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41416-020-01189-6","article-title":"Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients","volume":"124","author":"Yasui","year":"2021","journal-title":"Br J Cancer"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12974-023-02890-y","article-title":"The relationship between systemic inflammation index, systemic immune-inflammatory index, and inflammatory prognostic index and 90-day outcomes in acute ischemic stroke patients treated with intravenous thrombolysis","volume":"20","author":"Ma","year":"2023","journal-title":"J Neuroinflammation"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R24-20261030","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/jcsm.12837","article-title":"Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphoma","volume":"12","author":"Go","year":"2021","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1515\/biol-2020-0035","article-title":"Progress in research on the role of fibrinogen in lung cancer","volume":"15","author":"Liu","year":"2020","journal-title":"Open Life Sci"},{"key":"R26-20261030","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.2019001388","article-title":"Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin","volume":"134","author":"Suzuki-Inoue","year":"2019","journal-title":"Blood"},{"key":"R27-20261030","doi-asserted-by":"crossref","first-page":"1538285","DOI":"10.3389\/fnut.2025.1538285","article-title":"Prognostic impact of visceral and subcutaneous fat area in stage I-III colon cancer patients with cachexia: a population-based multicenter study","volume":"12","author":"Liang","year":"2025","journal-title":"Front Nutr"},{"key":"R28-20261030","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcsm.12307","article-title":"Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer","volume":"9","author":"Kays","year":"2018","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12944-017-0547-x","article-title":"Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer","volume":"16","author":"Silv\u00e9rio","year":"2017","journal-title":"Lipids Health Dis"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.clnu.2022.09.016","article-title":"Adipose tissue radiodensity and mortality among patients with nonmetastatic breast cancer","volume":"41","author":"Cheng","year":"2022","journal-title":"Clin Nutr"},{"key":"R31-20261030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clnesp.2020.07.007","article-title":"Fat density is a novel prognostic marker in patients with esophageal cancer","volume":"39","author":"Anciaux","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"R32-20261030","doi-asserted-by":"crossref","first-page":"1056.e1\u20131056.e10","DOI":"10.1016\/j.crad.2018.07.094","article-title":"Prognostic value of CT attenuation and FDG uptake of adipose tissue in patients with pancreatic adenocarcinoma","volume":"73","author":"Lee","year":"2018","journal-title":"Clin Radiol"},{"key":"R33-20261030","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1007\/s00330-016-4306-6","article-title":"Adipose tissue and muscle attenuation as novel biomarkers predicting mortality in patients with extremity sarcomas","volume":"26","author":"Veld","year":"2016","journal-title":"Eur Radiol"},{"key":"R34-20261030","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.clnu.2021.08.003","article-title":"Subcutaneous, but not visceral, adipose tissue as a marker for prognosis in gastric cancer patients with cachexia","volume":"40","author":"Han","year":"2021","journal-title":"Clin Nutr"},{"key":"R35-20261030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.critrevonc.2018.05.004","article-title":"The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: a systematic review and meta-analysis","volume":"127","author":"Qian","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"R36-20261030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12986-022-00694-0","article-title":"Browning of the white adipose tissue regulation: new insights into nutritional and metabolic relevance in health and diseases","volume":"19","author":"Machado","year":"2022","journal-title":"Nutr Metab (Lond)"},{"key":"R37-20261030","doi-asserted-by":"crossref","first-page":"1253587","DOI":"10.3389\/fimmu.2023.1253587","article-title":"Platelet status in cancer cachexia progression in ApcMin\/+ mice","volume":"14","author":"Cunningham","year":"2023","journal-title":"Front Immunol"},{"key":"R38-20261030","doi-asserted-by":"crossref","first-page":"131588","DOI":"10.1016\/j.ijcard.2023.131588","article-title":"Platelet to albumin ratio: a risk factor related to prognosis in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention","volume":"395","author":"Hao","year":"2024","journal-title":"Int J Cardiol"},{"key":"R39-20261030","doi-asserted-by":"crossref","first-page":"1166802","DOI":"10.3389\/fonc.2023.1166802","article-title":"Correlation analysis of hemoglobin, albumin, lymphocyte, platelet score and platelet to albumin ratio and prognosis in patients with lung adenosquamous carcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Oncol"},{"key":"R40-20261030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12916-025-03925-2","article-title":"Development and validation of the systemic nutrition\/inflammation index for improving perioperative management of non-small cell lung cancer","volume":"23","author":"Wang","year":"2025","journal-title":"BMC Med"},{"key":"R41-20261030","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"R42-20261030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jcsm.12200","article-title":"The influence of different muscle mass measurements on the diagnosis of cancer cachexia","volume":"8","author":"Blauwhoff-Buskermolen","year":"2017","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R43-20261030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argil\u00e9s","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"R44-20261030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/nyas.13454","article-title":"Coagulation and fibrinolysis in gastric cancer","volume":"1404","author":"Repetto","year":"2017","journal-title":"Ann N Y Acad Sci"},{"key":"R45-20261030","first-page":"457","article-title":"High fibrinogen and platelets correlate with poor survival in gastric cancer patients","volume":"50","author":"Zhang","year":"2020","journal-title":"Ann Clin Lab Sci"},{"key":"R46-20261030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00268-019-05191-9","article-title":"Is preoperative fibrinogen associated with the survival prognosis of gastric cancer patients? A multi-centered, propensity score-matched retrospective study","volume":"44","author":"Zhao","year":"2020","journal-title":"World J Surg"},{"key":"R47-20261030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2006.03.012","article-title":"Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer","volume":"53","author":"Jones","year":"2006","journal-title":"Lung Cancer"},{"key":"R48-20261030","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"R49-20261030","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"R50-20261030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/bmj.2.1075.198","article-title":"An address on the value of pathological experiments","volume":"2","author":"Virchow","year":"1881","journal-title":"Br Med J"},{"key":"R51-20261030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"R52-20261030","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.clnu.2024.07.026","article-title":"The combination of handgrip strength and CONUT predicts overall survival in patients with gastrointestinal cancer: a multicenter cohort study","volume":"43","author":"Jia","year":"2024","journal-title":"Clin Nutr"},{"key":"R54-20261030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10120-003-0245-4","article-title":"Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study","volume":"6","author":"Ott","year":"2003","journal-title":"Gastric Cancer"},{"key":"R55-20261030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejca.2016.04.012","article-title":"Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer","volume":"62","author":"Yoshikawa","year":"2016","journal-title":"Eur J Cancer"},{"key":"R56-20261030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10120-020-01098-w","article-title":"Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A","volume":"24","author":"Fujitani","year":"2021","journal-title":"Gastric Cancer"},{"key":"R57-20261030","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000002707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:05:07Z","timestamp":1793351107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000002707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002707","relation":{},"ISSN":["1743-9159","1743-9191"],"issn-type":[{"value":"1743-9159","type":"electronic"},{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"2025-03-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}